Author: Daniel Gerard Welch
Release Date: December 1, 2017
Rating: 5 Stars
Reviewer: Jessica Higgins
Probably the most informative medical thriller that I have ever read!
As the population grows in number and the average life span continues to lengthen, the number of cases of Alzheimer’s disease continue to increase as well. As the current leading untreatable disease in America, millions are affected every year. As the mind continues to degrade over time, family and loved ones can only watch and support the best they can, often having just as negative an effect on them as the actual person diagnosed. Hopefully one day, there will be medicine that can cure or at least recede the symptoms.
BioNeura, a small medicinal start-up company in San Francisco, has just determined that a new experimental drug that they have developed shows positive signs of deferment of the disease. But they lack the capital needed to get the drug mainstreamed so that it can be reviewed by the FDA. The group begins with a quest for venture capitalist partners to begin further development of the drug. What ensues is a step by step process of how the company must begin to make this drug available to the market, as well as the time that it takes to actually put the drug through trials, funding, marketing, and eventually a successful product lunch. But there are always antagonists along the way such as rival companies, activist groups, and sometimes even our most personal relationships. Race for the Mind is destined to become a hit.
This is probably the most informative medical thriller that I have ever read! I know a little bit about the process that it takes to have a drug considered and eventually approved by the FDA for market, but this book really took it to the next level to let the reader know just how long that it can take. Another interesting part of this book was the process of growing a small start-up company into one that handles full production, manufacturing, and distribution of products. It was very interesting to see the dynamic of the leadership and watch it unfold each time the company took a new step, be it a merger, acquisition, or going public. I loved watching a cast of unlikely characters who all initially meet at a conference in Las Vegas come together to create a great story.
I highly recommend this book to people who love a good thriller and anyone who is interested in Alzheimer’s disease.
I received a compliment copy of this title from the publisher. The views and opinions expressed within are my own.